Skip to Main Content

Paper Details

Comprehensive evaluation of surrogate endpoints to predict overall survival in trials with PD1/PD-L1 immune checkpoint inhibitors plus chemotherapy.
Cancer Treat Rev
0
2023
Author NameAffiliation
Rodrigo DienstmannVall d'Hebron Institute of Oncology (VHIO)
  • 1 - 1

Datasets

Release 1.2